Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-127-35-reactive T cells from activation-induced cell death

Cancer Research

Volumn 69, Issue 15, 2009, Pages 6282-6289

  Norell, Håkan ^a   Da Palma, Telma Martins ^a   Lesher, Aaron ^a   Kaur, Navtej ^a   Mehrotra, Meenal ^a   Naga, Osama S ^a   Spivey, Natalie ^a   Olafimihan, Seye ^a   Chakraborty, Nitya G ^b   Voelkel Johnson, Christina ^a   Nishimura, Michael I ^a   Mukherji, Bijay ^b   Mehrotra, Shikhar ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALANYLALANYLGLYCYLISOLEUCYLGLYCYLISOLEUCYLLEUCYLTHREONYLVANINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIOXIDANT; CD8 ANTIGEN; DNA; GAMMA INTERFERON; GLYCYLISOLEUCYLLEUCYLGLYCYLPHENYLALANYLVALYLPHENYLALANYLTHREONYLLEUCINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MANGANESE TETRAKIS(5,10,15,20 BENZOIC ACID)PORPHYRIN; MATRIX PROTEIN; MELAN A; PORPHYRIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SUPEROXIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL EXPANSION; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DEGRANULATION; DENDRITIC CELL; DNA FRAGMENTATION; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MELANOMA CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR ASSOCIATED LEUKOCYTE;

CELL DEATH; EPITOPES; EPITOPES, T-LYMPHOCYTE; FREE RADICAL SCAVENGERS; HLA-A2 ANTIGEN; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; METALLOPORPHYRINS; NEOPLASM PROTEINS; ORTHOMYXOVIRIDAE; RECEPTORS, ANTIGEN, T-CELL; SUPEROXIDES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EID: 68049133176     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1176     Document Type: Article

References (50)

1. Jaattela M. Programmed cell death: many ways for cells to die decently. Ann Med 2002;34:480-488 (Pubitemid 36026779)
2. Hildeman D, Jorgensen T, Kappler J, Marrack P. Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol 2007;19:516-521 (Pubitemid 47464912)
3. Lu B, Finn OJ. T-cell death and cancer immune tolerance. Cell Death Differ 2008;15:70-79 (Pubitemid 350286174)
4. Whiteside TL. Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy. Vaccine 2002;20 Suppl 4:A46-51.
5. Huang J, Khong HT, Dudley ME, et al. Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regression. J Immunother 2005;28:258-267 (Pubitemid 40593992)
6. Charo J, Finkelstein SE, Grewal N, Restifo NP, Robbins PF, Rosenberg SA. Bcl-2 overexpression enhances tumorspecific T-cell survival. Cancer Res 2005;65:2001-2008 (Pubitemid 40478630)
7. Robbins PF, Dudley ME, Wunderlich J, et al. Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J Immunol 2004;173:7125-7130 (Pubitemid 39628146)
8. Jaattela M, Tschopp J. Caspase-independent cell death in T lymphocytes. Nat Immunol 2003;4:416-423
9. Budd RC. Activation-induced cell death. Curr Opin Immunol 2001;13:356-362
10. Mehrotra S, Stevens R, Zengou R, et al. Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro . Cancer Res 2003;63:5607-5614 (Pubitemid 37139885)
11. Mehrotra S, Chhabra A, Chattopadhyay S, Dorsky DI, Chakraborty NG, Mukherji B. Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation- induced cell death, by SP600125, an inhibitor of JNK: implications in cancer immunotherapy. J Immunol 2004;173:6017-6024 (Pubitemid 39487756)
12. 2 terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death. J Leukoc Biol 2007;81:539-547
13. Murahashi H, Azuma H, Zamzami N, et al. Possible contribution of apoptosis-inducing factor (AIF) and reactive oxygen species (ROS) to UVB-induced caspaseindependent cell death in the T cell line Jurkat. J Leukoc Biol 2003;73:399-406. (Pubitemid 36790856)
14. Papa L, Gomes E, Rockwell P. Reactive oxygen species induced by proteasome inhibition in neuronal cells mediate mitochondrial dysfunction and a caspaseindependent cell death. Apoptosis 2007;12:1389-1405 (Pubitemid 46988276)
15. Hildeman DA, Mitchell T, Teague TK, et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 1999;10:735-744 (Pubitemid 29302926)
16. Hildeman DA, Mitchell T, Aronow B, Wojciechowski S, Kappler J, Marrack P. Control of Bcl-2 expression by reactive oxygen species. Proc Natl Acad Sci U S A 2003; 100:15035-15040 (Pubitemid 37518012)
17. Giannoni E, Buricchi F, Grimaldi G, et al. Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. Cell Death Differ 2008;15:867-878
18. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P. Redox regulation of cell survival. Antioxid Redox Signal 2008;10:1343-1374
19. Rosenberg SA, Dudley ME, Restifo NP. Cancer immunotherapy. N Engl J Med 2008;359:1072.
20. Yang JC, Childs R. Immunotherapy for renal cell cancer. J Clin Oncol 2006;24:5576-5583
21. Kawakami Y, Eliyahu S, Delgado CH, et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci U S A 1994;91:6458-6462 (Pubitemid 24984961)
22. Banki K, Hutter E, Gonchoroff NJ, Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. J Immunol 1999;162:1466-1479 (Pubitemid 29307019)
23. Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78.
24. Martinvalet D, Zhu P, Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity 2005;22: 355-370 (Pubitemid 40387477)
25. Green D, Kroemer G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol 1998;8:267-271
26. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem 1999; 264:687-701. (Pubitemid 29437197)
27. Peitsch MC, Muller C, Tschopp J. DNA fragmentation during apoptosis is caused by frequent single-strand cuts. Nucleic Acids Res 1993;21:4206-4209 (Pubitemid 23279007)
28. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L. Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp Cell Res 1996;226:387-397 (Pubitemid 26260564)
29. Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 298:850-854
30. Kurz DJ, Decary S, Hong Y, Trivier E, Akhmedov A, Erusalimsky JD. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci 2004;117: 2417-2426 (Pubitemid 38807508)
31. Schmitt F, Tani E, Tribukait B, Skoog L. Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas. Cytopathology 1999;10: 87-96. (Pubitemid 29166647)
32. Shen HM, Liu ZG. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med 2006;40:928-939
33. Zhang S, Lin Y, Kim YS, Hande MP, Liu ZG, Shen HM. c-Jun N-terminal kinase mediates hydrogen peroxideinduced cell death via sustained poly(ADP-ribose) polymerase-1 activation. Cell Death Differ 2007;14: 1001-1010 (Pubitemid 46629838)
34. Lenardo MJ. Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system. Immunol Res 2003;27:387-398
35. St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 2002;277:44784-44790 (Pubitemid 36159072)
36. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO. Requirement for superoxide in excitotoxic cell death. Neuron 1996;16:345-355 (Pubitemid 26072367)
37. Day BJ, Shawen S, Liochev SI, Crapo JD. A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury, in vitro . J Pharmacol Exp Ther 1995;275:1227-1232 (Pubitemid 26130633)
38. Zamzami N, Marchetti P, Castedo M, et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo . J Exp Med 1995;181:1661-1672
39. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995;182:367-377
40. Williams MS, Kwon J. T cell receptor stimulation, reactive oxygen species, and cell signaling. Free Radic Biol Med 2004;37:1144-1151 (Pubitemid 39296739)
41. Halliwell B. Biochemical mechanisms accounting for the toxic action of oxygen on living organisms: the key role of superoxide dismutase. Cell Biol Int Rep 1978;2: 113-128
42. Adler V, Yin Z, Tew KD, Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999;18:6104-6111
43. Kriehuber E, Bauer W, Charbonnier AS, et al. Balance between NF-κB and JNK/AP-1 activity controls dendritic cell life and death. Blood 2005;106:175-183 (Pubitemid 40967190)
44. Torres M, Forman HJ. Redox signaling and the MAP kinase pathways. Biofactors 2003;17:287-296 (Pubitemid 37267162)
45. Rincon M, Flavell RA, Davis RA. The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses. Free Radic Biol Med 2000;28:1328-1337 (Pubitemid 30621477)
46. Kovacic P, Somanathan R. Integrated approach to immunotoxicity: electron transfer, reactive oxygen species, antioxidants, cell signaling, and receptors. J Recept Signal Transduct Res 2008;28:323-346
47. Li-Weber M, Weigand MA, Giaisi M, et al. Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J Clin Invest 2002; 110:681-690 (Pubitemid 34988792)
48. Vig M, Srivastava S, Kandpal U, et al. Inducible nitric oxide synthase in T cells regulates T cell death and immune memory. J Clin Invest 2004;113:1734-1742 (Pubitemid 39071665)
49. Laniewski NG, Grayson JM. Antioxidant treatment reduces expansion and contraction of antigen-specific CD8+ T cells during primary but not secondary viral infection. J Virol 2004;78:11246-11257
50. Ando T, Mimura K, Johansson CC, et al. Transduction with the antioxidant enzyme catalase protects human T cells against oxidative stress. J Immunol 2008; 181:8382-8390